Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 14/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 14/20 | 0.39 |
| ▸ | KDM1A | O60341 | 2/20 | 0.36 |
| ▸ | RCOR1 | Q9UKL0 | 2/20 | 0.36 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12132806 | 0.84 | SLC6A4 (0.37) | SLC6A4SLC6A3KDM1ARCOR1UTS2R | |
| SCHEMBL12132810 | 0.84 | SLC6A4 (0.37) | SLC6A4SLC6A3KDM1ARCOR1UTS2R | |
| SCHEMBL12132812 | 0.83 | SLC6A4 (0.39) | SLC6A4SLC6A3KDM1ARCOR1UTS2R | |
| SCHEMBL12662787 | 0.82 | GRIN1 (0.36) | — | |
| SCHEMBL13502573 | 0.81 | SLC6A4 (0.37) | SLC6A4SLC6A3KDM1ARCOR1UTS2R | |
| SCHEMBL13502571 | 0.80 | HTR1A (0.34) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL13502568 | 0.80 | HTR1A (0.36) | UTS2R | |
| SCHEMBL13502565 | 0.77 | HSP90AA1 (0.38) | SLC6A3SLC6A2 | |
| SCHEMBL13502567 | 0.77 | HSD11B1 (0.33) | SLC6A3SLC6A2 | |
| SCHEMBL13502575 | 0.76 | MAOB (0.36) | SLC6A4SLC6A3SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2325178-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE COMPOUND | DAISO CO., LTD. (JP) | 2011-05-25 | — | — | EP | disclosed |
| WO-2010013510-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE COMPOUND | ダイソー株式会社 (JP) | 2010-02-04 | — | — | WO | disclosed |